| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 25.06▲ | 25.23▼ | 25.37▼ | 25.78▼ | 24.57▲ |
| MA10 | 25.13▼ | 25.55▼ | 25.56▼ | 25.38▼ | 23.18▲ |
| MA20 | 25.26▼ | 25.49▼ | 25.67▼ | 24.60▲ | 22.17▲ |
| MA50 | 25.55▼ | 25.68▼ | 25.31▼ | 23.11▲ | 17.24▲ |
| MA100 | 25.58▼ | 25.24▼ | 25.08▲ | 22.39▲ | 15.49▲ |
| MA200 | 25.61▼ | 24.93▲ | 23.72▲ | 18.90▲ | 17.89▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.075▼ | -0.097▼ | 0.009▲ | 0.151▲ |
| RSI | 36.212▼ | 41.251▼ | 42.474▼ | 54.607▲ | 63.680▲ |
| STOCH | 15.370▼ | 8.738▼ | 50.272 | 60.808 | 68.493 |
| WILL %R | -79.070▼ | -92.800▼ | -58.883 | -42.857 | -35.571 |
| CCI | -71.385 | -130.847▼ | -104.716▼ | 19.247 | 133.714▲ |
|
Wednesday, May 06, 2026 12:18 AM
Arcus Biosciences (NYSE:RCUS) ended its Phase 3 STAR-121 lung cancer trial after a futility analysis indicated the study was unlikely to meet its goals. Gilead decided not to continue its broad option ...
|
|
Tuesday, May 05, 2026 09:23 PM
Q1 2026 earnings call: casdatifan PEAK-1 Phase III progress, STAR-121 halted, raised revenue guide & cash runway.
|
|
Monday, May 04, 2026 07:35 AM
This article first appeared on GuruFocus. Arcus Biosciences Inc (NYSE:RCUS) is set to release its Q1 2026 earnings on May 5, 2026. The consensus estimate for Q1 2026 revenue is $0.03 billion, and the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/05/26 | 25.56 | 25.87 | 25.00 | 25.09 | 254,084 |
| 06/05/26 | 25.02 | 26.28 | 24.2001 | 26.00 | 1,825,420 |
| 05/05/26 | 26.39 | 26.70 | 25.245 | 26.06 | 1,150,064 |
| 04/05/26 | 25.55 | 26.38 | 25.45 | 26.05 | 1,223,768 |
| 01/05/26 | 25.65 | 25.995 | 25.10 | 25.68 | 986,390 |
| 30/04/26 | 24.46 | 25.69 | 24.05 | 25.50 | 939,330 |
| 29/04/26 | 24.42 | 24.6299 | 23.91 | 24.13 | 843,153 |
| 28/04/26 | 24.88 | 25.47 | 24.1203 | 24.80 | 1,311,087 |
| 27/04/26 | 25.42 | 26.20 | 24.88 | 24.95 | 953,629 |
| 24/04/26 | 25.48 | 25.91 | 24.59 | 25.50 | 729,297 |
|
|
||||
|
|
||||
|
|